<VariationArchive RecordType="classified" VariationID="1188836" VariationName="NM_031448.6(C19orf12):c.182dup (p.Leu61fs)" VariationType="Duplication" Accession="VCV001188836" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-25" DateCreated="2021-08-07" MostRecentSubmission="2021-08-07">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1178843" VariationID="1188836">
      <GeneList>
        <Gene Symbol="C19orf12" FullName="chromosome 19 open reading frame 12" GeneID="83636" HGNC_ID="HGNC:25443" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19q12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="29698886" stop="29715789" display_start="29698886" display_stop="29715789" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="30189792" stop="30206695" display_start="30189792" display_stop="30206695" Strand="-" />
          </Location>
          <OMIM>614297</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_031448.6(C19orf12):c.182dup (p.Leu61fs)</Name>
      <CanonicalSPDI>NC_000019.10:29702955:AA:AAA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>19q12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="29702955" stop="29702956" display_start="29702955" display_stop="29702956" variantLength="1" positionVCF="29702955" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="30193862" stop="30193863" display_start="30193862" display_stop="30193863" variantLength="1" positionVCF="30193862" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
      </Location>
      <ProteinChange>L61fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.29702957dup" Assembly="GRCh38">
            <Expression>NC_000019.10:g.29702957dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.30193864dup" Assembly="GRCh37">
            <Expression>NC_000019.9:g.30193864dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_031970.2" sequenceAccession="NG_031970" sequenceVersion="2" change="g.17834dup">
            <Expression>NG_031970.2:g.17834dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001031726.4" sequenceAccession="NM_001031726" sequenceVersion="4" change="c.182dup">
            <Expression>NM_001031726.4:c.182dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001026896.3" sequenceAccession="NP_001026896" sequenceVersion="3" change="p.Leu61fs">
            <Expression>NP_001026896.3:p.Leu61fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001256046.3" sequenceAccession="NM_001256046" sequenceVersion="3" change="c.182dup">
            <Expression>NM_001256046.3:c.182dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001242975.1" sequenceAccession="NP_001242975" sequenceVersion="1" change="p.Leu61fs">
            <Expression>NP_001242975.1:p.Leu61fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001256047.2" sequenceAccession="NM_001256047" sequenceVersion="2" change="c.182dup">
            <Expression>NM_001256047.2:c.182dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001242976.1" sequenceAccession="NP_001242976" sequenceVersion="1" change="p.Leu61fs">
            <Expression>NP_001242976.1:p.Leu61fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282929.1" sequenceAccession="NM_001282929" sequenceVersion="1" change="c.-11dup">
            <Expression>NM_001282929.1:c.-11dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282930.3" sequenceAccession="NM_001282930" sequenceVersion="3" change="c.-11dup">
            <Expression>NM_001282930.3:c.-11dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282931.3" sequenceAccession="NM_001282931" sequenceVersion="3" change="c.-11dup">
            <Expression>NM_001282931.3:c.-11dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_031448.6" sequenceAccession="NM_031448" sequenceVersion="6" change="c.182dup" MANESelect="true">
            <Expression>NM_031448.6:c.182dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_113636.2" sequenceAccession="NP_113636" sequenceVersion="2" change="p.Leu61fs">
            <Expression>NP_113636.2:p.Leu61fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2145623001" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_031448.6(C19orf12):c.182dup (p.Leu61fs) AND Neurodegeneration with brain iron accumulation 4" Accession="RCV001548764" Version="1">
        <ClassifiedConditionList TraitSetID="7628">
          <ClassifiedCondition DB="MedGen" ID="C3280371">Neurodegeneration with brain iron accumulation 4</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2020-02-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-02-14" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-08-07" MostRecentSubmission="2021-08-07">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="7628" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16586" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Neurodegeneration with brain iron accumulation 4</ElementValue>
                <XRef ID="MONDO:0013674" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MITOCHONDRIAL PROTEIN-ASSOCIATED NEURODEGENERATION</ElementValue>
                <XRef Type="MIM" ID="614298" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">NBIA4</ElementValue>
                <XRef Type="MIM" ID="614298" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MPAN</ElementValue>
                <XRef Type="MIM" ID="614298" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000512825" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508834" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520058" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552041" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000553865" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528698" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000553399" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529414" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Mitochondrial membrane protein-associated neurodegeneration (MPAN) is characterized initially by gait changes followed by progressive spastic paresis, progressive dystonia (which may be limited to the hands and feet or more generalized), neuropsychiatric abnormalities (emotional lability, depression, anxiety, impulsivity, compulsions, hallucinations, perseveration, inattention, and hyperactivity), and cognitive decline. Additional early findings can include dysphagia, dysarthria, optic atrophy, axonal neuropathy, parkinsonism, and bowel/bladder incontinence. Survival is usually well into adulthood. End-stage disease is characterized by severe dementia, spasticity, dystonia, and parkinsonism.</Attribute>
                <XRef ID="NBK185329" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12569" />
                <XRef ID="12569" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23447832</ID>
                <ID Source="BookShelf">NBK121988</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">24575447</ID>
                <ID Source="BookShelf">NBK185329</ID>
              </Citation>
              <XRef ID="289560" DB="Orphanet" />
              <XRef ID="C3280371" DB="MedGen" />
              <XRef ID="MONDO:0013674" DB="MONDO" />
              <XRef Type="MIM" ID="614298" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3473507" SubmissionDate="2021-07-15" DateLastUpdated="2021-08-07" DateCreated="2021-08-07">
        <ClinVarSubmissionID localKey="NC_000019.9:g.30193863dupA|OMIM:614298" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001768728" DateUpdated="2021-08-07" DateCreated="2021-08-07" Type="SCV" Version="1" SubmitterName="Gene Discovery Core-Manton Center, Boston Children's Hospital" OrgID="505675" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-02-14">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant is interpreted as Pathogenic for Neurodegeneration with brain iron accumulation 4; Autosomal Recessive. PVS1- Null variant (frameshift) in a gene where LOF is a known mechanism of disease. PM2- Absent from controls (gnomad). PP3- Multiple lines of computational evidence support a deleterious effect on the gene or gene product (conservation, evolutionary, splicing impact, etc.)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="C19orf12" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.30193863dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614298" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10009842</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3473507" TraitType="Disease" MappingType="XRef" MappingValue="614298" MappingRef="OMIM">
        <MedGen CUI="C3280371" Name="Neurodegeneration with brain iron accumulation 4" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

